非血管ステントの世界市場：企業動向...市場調査レポートについてご紹介

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Competitive Assessment
3.1 Gastrointestinal Stents
3.1.1 Overview
3.1.2 WallFlex (Boston Scientific Corporation)
3.1.3 Evolution (Cook Medical)
3.1.4 Niti-S (Taewoong Medical)
3.1.5 Other Key Marketed Gastrointestinal Stents
3.2 Biliary Stents
3.2.1 Overview
3.2.2 WallFlex Biliary RX (Boston Scientific Corporation)
3.2.3 Cotton-Leung (Amsterdam) (Cook Medical)
3.2.4 Bonastent (EndoChoice)
3.2.5 Other Key Marketed Biliary Stents
3.3 Airway Stents
3.3.1 Overview
3.3.2 Dumon (Novatech)
3.3.3 Aero/Aero DV (Merit Endotek)
3.3.4 Ultraflex (Boston Scientific Corporation)
3.3.5 Other Key Marketed Airway Stents
3.4 Urinary Tract Stents
3.4.1 Overview
3.4.2 Polaris Ultra (Boston Scientific Corporation)
3.4.3 InLay Optima (C.R. Bard)
3.4.4 Other Key Marketed Urinary Tract Stents
4 Current and Future Players
4.1 Trends in Corporate Strategy
4.2 Company Profiles
4.2.1 Allium Medical
4.2.2 Boston Scientific Corporation
4.2.3 ConMed
4.2.4 Cook Medical
4.2.5 C.R. Bard
4.2.6 Ella-CS
4.2.7 Merit Endotek
4.2.8 M.I. Tech
4.2.9 Micro-Tech (Nanjing)
4.2.10 Medtronic (Covidien)
4.2.11 Novatech
4.2.12 Olympus
4.2.13 Taewoong Medical
4.2.14 Xlumena
4.2.15 Other Companies
4.2.16 Urinary Tract Stents
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Research Methodology
5.3.1 Overview
5.3.2 Coverage
5.3.3 Secondary Research
5.4 Physicians and Specialists Included in this Study
5.5 Primary Research
5.5.1 Primary Research – Key Opinion Leader Interviews
5.5.2 Primary Research – Physician and Industry Interviews
5.5.3 Expert Panel Validation
5.6 Forecasting Methodology
5.7 About the Authors
5.7.1 Analysts
5.7.2 Global Head of Healthcare
5.8 About MediPoint
5.9 About GlobalData
5.10 Disclaimer